Area of research
Reproductive Medicine · Cancer Research
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Breast Cancer Treatment Studies, PARP inhibition in cancer therapy, and Endometrial and Cervical Cancer Treatments.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial